Wolverine Trading’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-27,272
Closed -$38.7K 6029
2025
Q2
$38.7K Buy
27,272
+4,355
+19% +$6.19K ﹤0.01% 4399
2025
Q1
$36.4K Buy
22,917
+12,623
+123% +$19.9K ﹤0.01% 4487
2024
Q4
$9.61K Buy
+10,294
New +$8.78K ﹤0.01% 5160
2023
Q1
Sell
-23,535
Closed -$33.9K 4766
2022
Q4
$36K Buy
23,535
+9,258
+65% +$15.9K ﹤0.01% 3642
2022
Q3
$29K Sell
14,277
-4,738
-25% -$9.99K ﹤0.01% 4304
2022
Q2
$26K Buy
19,015
+251
+1% +$372 ﹤0.01% 4197
2022
Q1
$40K Sell
18,764
-14,679
-44% -$35.7K ﹤0.01% 5136
2021
Q4
$128K Buy
33,443
+20,781
+164% +$89.4K ﹤0.01% 4970
2021
Q3
$64K Buy
+12,662
New +$72.9K ﹤0.01% 5962
2021
Q2
Sell
-14,483
Closed -$101K 6522
2021
Q1
$98K Buy
+14,483
New +$122K ﹤0.01% 5442
2020
Q1
Sell
-22,961
Closed -$126K 5094
2019
Q4
$126K Buy
22,961
+7,170
+45% +$40.4K ﹤0.01% 4216
2019
Q3
$87K Buy
+15,791
New +$107K ﹤0.01% 3898

Other funds holding PGEN

Wolverine Trading's PGEN Position: Q3 2025 in Review

Wolverine Trading sold out of Precigen (PGEN) in Q3 2025, closing a stake of 27,272 shares — an estimated $38.7K sold.

Wolverine Trading first reported a position in PGEN in Q3 2019 and held it in 12 quarters. The position peaked at $128K in Q4 2021. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

  • Wolverine Trading reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 27,272 Precigen shares in Q3 2025, an estimated $38.7K.
  • Wolverine Trading first reported a position in Precigen in Q3 2019 and held it in 12 quarters.
  • Wolverine Trading's Precigen position peaked at $128K in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.